GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
LEHI, Utah, Oct. 25, 2017 -- Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced that it will report its third quarter 2017 financial results for the period ended September 30, 2017, on Wednesday, November 8, 2017, after the market close. Members of Nature’s Sunshine Products’ senior management team will host a conference call that same day at 5:30 p.m. Eastern Time. The call will be broadcast live over the Internet hosted on the Investor’s Events section of the Company’s website at www.naturessunshine.com.
|
|||||
| Nature’s Sunshine Products’ Third Quarter 2017 Conference Call Details | |||||
| Date: | Wednesday, November 8, 2017 | ||||
| Time: | 2:30 p.m. Pacific Time | ||||
| 3:30 p.m. Mountain Time | |||||
| 5:30 p.m. Eastern Time | |||||
| Dial-In: | 1-877-423-9813 (domestic) | ||||
| 1-201-689-8573 (international) | |||||
| Conference ID: | 13672822 | ||||
| Webcast: | Investor section of the Company’s website at www.naturessunshine.com | ||||
For those unable to participate during the live broadcast, a replay of the call will also be available beginning that same day at 8:30 p.m. Eastern Time, until 11:59 p.m. Eastern Time, on Wednesday, November 22, 2017, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the replay pin number: 13672822. The webcast will remain on the Investor’s Events section of Nature’s Sunshine Products’ website at: www.naturessunshine.com for 90 days.
About Nature’s Sunshine Products
Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products through a global direct sales force of over 516,000 independent Managers, Distributors and customers in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. The Company has four reportable business segments that are divided based on the characteristics of their Distributor base, similarities in compensation plans, as well as the internal organization of NSP’s officers and their responsibilities (NSP Americas; NSP Russia, Central and Eastern Europe; Synergy WorldWide; and China and New Markets). The Company also supports health and wellness for children around the world through its partnership with the Sunshine Heroes Foundation. Additional information about the Company can be obtained at its website, www.naturessunshine.com.
Contact:
Scott Van Winkle
Managing Director
ICR
(617) 956-6736
